Sartorius Stedim Biotech (FR:DIM)
PARIS:DIM

Sartorius Stedim Biotech (DIM) Financial Statements

8 Followers

Sartorius Stedim Biotech Financial Overview

Sartorius Stedim Biotech's market cap is currently ―. The company's EPS TTM is €1.779; its P/E ratio is 98.21; and it has a dividend yield of 0.39%. Sartorius Stedim Biotech is scheduled to report earnings on October 17, 2024, and the estimated EPS forecast is €0.99. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue€ 890.00M€ 878.40M€ 861.80M€ 862.50M€ 778.20M
Gross Profit€ 473.10M€ 461.00M€ 445.90M€ 454.50M€ 403.80M
EBIT€ 216.20M€ 289.50M€ 294.50M€ 348.80M€ -6.20M
EBITDA€ 272.30M€ 331.70M€ 337.20M€ 389.50M€ 33.70M
Net Income Common Stockholders€ 186.70M€ 204.50M€ 214.80M€ 270.10M€ -8.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 133.00M€ 161.70M€ 181.00M€ 212.20M€ 237.30M
Total Assets€ 5.07B€ 5.10B€ 4.38B€ 4.16B€ 3.95B
Total Debt€ 1.14B€ 1.17B€ 732.20M€ 630.90M€ 625.50M
Net Debt€ 1.00B€ 1.00B€ 551.20M€ 418.70M€ 388.20M
Total Liabilities-----
Stockholders Equity€ 2.45B€ 2.27B€ 2.05B€ 1.92B€ 1.66B
Cash Flow-
Free Cash Flow€ 77.70M€ 36.60M€ -24.60M€ 92.00M€ 27.30M
Operating Cash Flow€ 219.60M€ 145.40M€ 78.10M€ 169.20M€ 165.30M
Investing Cash Flow€ -148.00M€ -584.60M€ -103.90M€ -121.00M€ -137.30M
Financing Cash Flow€ -105.60M€ 424.00M€ 9.80M€ -107.50M€ -36.70M
Currency in EUR

Sartorius Stedim Biotech Earnings and Revenue History

Sartorius Stedim Biotech Debt to Assets

Sartorius Stedim Biotech Cash Flow

Sartorius Stedim Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis